**Core Concept**
Anakinra is an interleukin-1 (IL-1) receptor antagonist, which means it works by blocking the action of IL-1, a pro-inflammatory cytokine involved in the pathogenesis of rheumatoid arthritis.

**Why the Correct Answer is Right**
Anakinra specifically binds to the IL-1 receptor, preventing the binding of IL-1 to its receptor and thus inhibiting the inflammatory response. This mechanism of action is particularly useful in treating conditions like rheumatoid arthritis, where IL-1 plays a significant role in the inflammation and joint damage. Anakinra's unique mechanism of action makes it an effective treatment option for patients with rheumatoid arthritis who have not responded to other therapies.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not accurately describe Anakinra's mechanism of action. Anakinra is not an IL-6 receptor antagonist, and its effects on IL-6 are not its primary mechanism of action.
**Option B:** This option is incorrect because it does not accurately describe Anakinra's mechanism of action. Anakinra is not a tumor necrosis factor-alpha (TNF-alpha) inhibitor, and its effects on TNF-alpha are not its primary mechanism of action.
**Option C:** This option is incorrect because it does not accurately describe Anakinra's mechanism of action. Anakinra is not a corticosteroid, and its effects on inflammation are not mediated through steroid receptors.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that Anakinra is a biologic agent that requires careful monitoring for potential side effects, such as increased risk of infections. This is because Anakinra can suppress the immune system, making patients more susceptible to infections.

**Correct Answer:** D. Anakinra is an interleukin-1 (IL-1) receptor antagonist used in the treatment of rheumatoid arthritis.